Simulations Plus (NASDAQ:SLP) Receives Outperform Rating from William Blair

William Blair reiterated their outperform rating on shares of Simulations Plus (NASDAQ:SLP) in a research report released on Thursday, Benzinga reports.

A number of other equities analysts have also weighed in on the company. BTIG Research decreased their target price on Simulations Plus from $60.00 to $50.00 and set a “buy” rating for the company in a research report on Thursday. KeyCorp assumed coverage on shares of Simulations Plus in a report on Monday, July 29th. They set an “overweight” rating and a $47.00 price objective for the company. JMP Securities initiated coverage on shares of Simulations Plus in a report on Tuesday, July 16th. They issued a “market perform” rating on the stock. Finally, Craig Hallum reiterated a “buy” rating and set a $56.00 target price on shares of Simulations Plus in a research note on Wednesday, July 3rd. One investment analyst has rated the stock with a hold rating and five have issued a buy rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $54.50.

Simulations Plus Stock Performance

Shares of NASDAQ:SLP traded down $0.48 during trading on Thursday, reaching $30.48. 21,468 shares of the stock traded hands, compared to its average volume of 128,810. The stock has a market cap of $609.90 million, a P/E ratio of 64.50 and a beta of 0.69. The stock has a 50-day moving average of $33.20 and a two-hundred day moving average of $40.76. Simulations Plus has a 52-week low of $29.37 and a 52-week high of $51.22.

Simulations Plus (NASDAQ:SLP) last issued its earnings results on Wednesday, October 23rd. The technology company reported $0.06 EPS for the quarter, beating the consensus estimate of $0.04 by $0.02. Simulations Plus had a return on equity of 7.80% and a net margin of 14.36%. The business had revenue of $18.70 million for the quarter, compared to the consensus estimate of $19.73 million. During the same period last year, the business posted $0.18 EPS. The company’s revenue was up 19.9% compared to the same quarter last year. Sell-side analysts expect that Simulations Plus will post 0.54 earnings per share for the current year.

Insider Buying and Selling

In other news, Director Walter S. Woltosz sold 20,000 shares of the business’s stock in a transaction on Tuesday, September 3rd. The shares were sold at an average price of $35.18, for a total transaction of $703,600.00. Following the completion of the sale, the director now owns 3,501,592 shares of the company’s stock, valued at $123,186,006.56. The trade was a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Over the last quarter, insiders have sold 60,750 shares of company stock valued at $2,145,055. 20.90% of the stock is owned by insiders.

Institutional Inflows and Outflows

Large investors have recently made changes to their positions in the stock. Semanteon Capital Management LP purchased a new stake in Simulations Plus in the 3rd quarter worth approximately $358,000. Tributary Capital Management LLC boosted its position in shares of Simulations Plus by 54.7% in the third quarter. Tributary Capital Management LLC now owns 325,567 shares of the technology company’s stock worth $10,425,000 after purchasing an additional 115,122 shares during the period. Trust Point Inc. increased its stake in shares of Simulations Plus by 27.5% in the third quarter. Trust Point Inc. now owns 11,994 shares of the technology company’s stock worth $384,000 after purchasing an additional 2,589 shares in the last quarter. nVerses Capital LLC raised its position in shares of Simulations Plus by 1,100.0% during the 3rd quarter. nVerses Capital LLC now owns 1,200 shares of the technology company’s stock valued at $38,000 after purchasing an additional 1,100 shares during the period. Finally, Kings Path Partners LLC lifted its stake in shares of Simulations Plus by 19.2% during the 3rd quarter. Kings Path Partners LLC now owns 22,560 shares of the technology company’s stock valued at $722,000 after buying an additional 3,633 shares in the last quarter. 78.08% of the stock is owned by hedge funds and other institutional investors.

Simulations Plus Company Profile

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.